http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001527038-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate | 1998-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2001527038-A |
| titleOfInvention | R-Procyclidin for treating urinary incontinence |
| abstract | (57) [Summary]nA method for treating urinary incontinence, such as incontinence due to bladder detrusor instability, using (R) -procyclidin enriched as an enantiomer. The method comprises administering a therapeutically effective amount of enriched (R) -procyclidin or a pharmaceutically acceptable salt thereof as an enantiomer substantially free of the (S) -procyclidin enantiomer. The step of performing Also disclosed is a pharmaceutical composition for the treatment of urinary incontinence comprising (R) -procyclidin enriched as an enantiomer or a pharmaceutically acceptable salt thereof and an acceptable carrier. |
| priorityDate | 1997-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.